1. Stocks
  2. Mankind Pharma Ltd.
  3. Swot
swot-logo

Mankind Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Mankind Pharma Ltd. has 11 Strengths, 9 Weaknesses, 0 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Consistent Highest Return Stocks over Five Years

Expensive Performers (DVM)

Relative Outperformance versus Industry over 1 Week

Growth in Net Profit with increasing Profit Margin (QoQ)

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

High Volume, High Gain

Top Gainers

Volume Shockers

Promoter decreasing their shareholding

PE higher than Industry PE

PEG greater than Industry PEG

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

Increasing Trend in Non-Core Income

Declining profitability: Falling ROCE

Stocks Underperforming their Industry Price Change in the Quarter

Companies with high market cap, lower public shareholding

Broker downgrades in price or recommendation in the past one month

MFs decreased their shareholding last quarter

Bullish or Bearish Candlestick Strength - Indices

Bullish Harami (Bullish Reversal)

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks